Morgan Stanley
TMDX icon

Morgan Stanley’s Transmedics TMDX Stock Holding History

Morgan Stanley’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.9M Sell
405,112
-289,038
-42% -$24.5M ﹤0.01% 2821
2026
Q1 		$69M Buy
694,150
+26,389
+4% +$3.44M ﹤0.01% 1780
2025
Q4 		$81.2M Buy
667,761
+119,942
+22% +$15.1M ﹤0.01% 1630
2025
Q3 		$61.5M Sell
547,819
-184,989
-25% -$21.7M ﹤0.01% 1839
2025
Q2 		$98.2M Buy
732,808
+133,748
+22% +$14.7M 0.01% 1345
2025
Q1 		$40.3M Buy
599,060
+144,622
+32% +$9.95M ﹤0.01% 2009
2024
Q4 		$28.3M Sell
454,438
-68,467
-13% -$6.37M ﹤0.01% 2401
2024
Q3 		$82.1M Buy
522,905
+11,269
+2% +$1.74M 0.01% 1398
2024
Q2 		$77.1M Buy
511,636
+66,729
+15% +$8M 0.01% 1369
2024
Q1 		$32.9M Sell
444,907
-34,939
-7% -$2.88M ﹤0.01% 2158
2023
Q4 		$37.9M Sell
479,846
-33,951
-7% -$2.05M ﹤0.01% 2012
2023
Q3 		$28.1M Sell
513,797
-77,547
-13% -$5.58M ﹤0.01% 2099
2023
Q2 		$49.7M Buy
591,344
+60,459
+11% +$4.63M ﹤0.01% 1580
2023
Q1 		$40.2M Buy
530,885
+197,998
+59% +$13.7M ﹤0.01% 1748
2022
Q4 		$20.5M Sell
332,887
-35,689
-10% -$1.9M ﹤0.01% 2318
2022
Q3 		$15.4M Buy
368,576
+307,301
+502% +$13.4M ﹤0.01% 2486
2022
Q2 		$1.93M Buy
61,275
+35,729
+140% +$953K ﹤0.01% 4567
2022
Q1 		$688K Sell
25,546
-27,870
-52% -$499K ﹤0.01% 5211
2021
Q4 		$1.02M Sell
53,416
-72,742
-58% -$1.82M ﹤0.01% 5053
2021
Q3 		$4.17M Buy
126,158
+103,645
+460% +$3.17M ﹤0.01% 3927
2021
Q2 		$747K Sell
22,513
-92,094
-80% -$2.55M ﹤0.01% 5251
2021
Q1 		$4.75M Buy
114,607
+85,418
+293% +$2.63M ﹤0.01% 3467
2020
Q4 		$581K Buy
29,189
+1,800
+7% +$26.6K ﹤0.01% 4987
2020
Q3 		$378K Buy
27,389
+7,134
+35% +$122K ﹤0.01% 4780
2020
Q2 		$363K Buy
20,255
+8,049
+66% +$126K ﹤0.01% 4769
2020
Q1 		$147K Sell
12,206
-89,841
-88% -$1.51M ﹤0.01% 5013
2019
Q4 		$1.94M Buy
102,047
+86,477
+555% +$1.59M ﹤0.01% 4063
2019
Q3 		$370K Sell
15,570
-3,352
-18% -$80.4K ﹤0.01% 4826
2019
Q2 		$548K Buy
+18,922
New +$517K ﹤0.01% 4565

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Morgan Stanley's TMDX Position: Q2 2026 in Review

Morgan Stanley reduced its Transmedics (TMDX) stake by 42% in Q2 2026, selling an estimated $24.5M and leaving 405,112 shares worth $26.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2821.

Morgan Stanley first reported a position in TMDX in Q2 2019 and has held it in 29 quarters since. The position peaked at $98.2M in Q2 2025. 374 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Morgan Stanley held 405,112 shares of Transmedics worth $26.9M as of Q2 2026.
  • Morgan Stanley sold 289,038 Transmedics shares in Q2 2026, an estimated $24.5M.
  • Transmedics made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #2821 holding.
  • Morgan Stanley first reported a position in Transmedics in Q2 2019 and has held it in 29 quarters since.
  • Morgan Stanley's Transmedics position peaked at $98.2M in Q2 2025.
  • 374 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.